Would you consider a focal prostate boost per FLAME trial with treatment of the pelvis?
Answer from: Radiation Oncologist at Academic Institution
The FLAME III trial evaluated a focal dose boost to the prostate tumor if it could be achieved without exceeding dose constraints. By extension, if you can achieve escalated dose to the tumor without meaningfully affecting your plan quality from an OAR perspective, I think this is a very reasonable ...
Comments
Radiation Oncologist at Center for Neurosciences Can anyone link the supplemental data with the dos...
Radiation Oncologist at SwedishAmerican Regional Cancer Center Kerkmeijer et al., PMID 33471548 (Data Supplement)...
Can anyone link the supplemental data with the dos...
Kerkmeijer et al., PMID 33471548 (Data Supplement)...